Global Human Rabies Vaccine Supply, Demand and Key Producers, 2024-2030

Page: 120

Published Date: 13 Sep 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus. There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.

The global Human Rabies Vaccine market size is expected to reach $ 1512 million by 2030, rising at a market growth of 4.2% CAGR during the forecast period (2024-2030).

The increasing awareness of rabies prevention and the rising number of reported cases of animal bites, particularly in developing countries, are key drivers of the human rabies vaccine market. Government-led vaccination programs, international health initiatives, and educational campaigns have significantly boosted demand for pre- and post-exposure prophylaxis, including human rabies vaccines. Moreover, improvements in vaccine technology, such as the development of safer and more effective vaccines, are also contributing to the growth of the market.

One major challenge in the human rabies vaccine market is the uneven access to vaccines, especially in regions where rabies is endemic. High costs, cold chain requirements for storage, and distribution challenges in rural or underdeveloped areas make it difficult for healthcare providers to ensure timely vaccination. Additionally, a lack of healthcare infrastructure and trained personnel to administer the vaccine can hinder its effectiveness in regions most affected by rabies, limiting the overall impact of vaccination efforts.

Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share. Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.

This report studies the global Human Rabies Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Human Rabies Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Rabies Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Human Rabies Vaccine total production and demand, 2019-2030, (K Units)
Global Human Rabies Vaccine total production value, 2019-2030, (USD Million)
Global Human Rabies Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Human Rabies Vaccine consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Human Rabies Vaccine domestic production, consumption, key domestic manufacturers and share
Global Human Rabies Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Human Rabies Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Human Rabies Vaccine production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Human Rabies Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological, ZhongKe Biopharm, Ningbo Rongan Biological, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Rabies Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Human Rabies Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Human Rabies Vaccine Market, Segmentation by Type:
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others

Global Human Rabies Vaccine Market, Segmentation by Application:
Pre-Exposure Vaccine
Post-Exposure Vaccine

Companies Profiled:
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals

Key Questions Answered:
1. How big is the global Human Rabies Vaccine market?
2. What is the demand of the global Human Rabies Vaccine market?
3. What is the year over year growth of the global Human Rabies Vaccine market?
4. What is the production and production value of the global Human Rabies Vaccine market?
5. Who are the key producers in the global Human Rabies Vaccine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Human Rabies Vaccine Introduction
    1.2 World Human Rabies Vaccine Supply & Forecast
        1.2.1 World Human Rabies Vaccine Production Value (2019 & 2023 & 2030)
        1.2.2 World Human Rabies Vaccine Production (2019-2030)
        1.2.3 World Human Rabies Vaccine Pricing Trends (2019-2030)
    1.3 World Human Rabies Vaccine Production by Region (Based on Production Site)
        1.3.1 World Human Rabies Vaccine Production Value by Region (2019-2030)
        1.3.2 World Human Rabies Vaccine Production by Region (2019-2030)
        1.3.3 World Human Rabies Vaccine Average Price by Region (2019-2030)
        1.3.4 North America Human Rabies Vaccine Production (2019-2030)
        1.3.5 Europe Human Rabies Vaccine Production (2019-2030)
        1.3.6 China Human Rabies Vaccine Production (2019-2030)
        1.3.7 India Human Rabies Vaccine Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Human Rabies Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Human Rabies Vaccine Major Market Trends

2 Demand Summary
    2.1 World Human Rabies Vaccine Demand (2019-2030)
    2.2 World Human Rabies Vaccine Consumption by Region
        2.2.1 World Human Rabies Vaccine Consumption by Region (2019-2024)
        2.2.2 World Human Rabies Vaccine Consumption Forecast by Region (2025-2030)
    2.3 United States Human Rabies Vaccine Consumption (2019-2030)
    2.4 China Human Rabies Vaccine Consumption (2019-2030)
    2.5 Europe Human Rabies Vaccine Consumption (2019-2030)
    2.6 Japan Human Rabies Vaccine Consumption (2019-2030)
    2.7 South Korea Human Rabies Vaccine Consumption (2019-2030)
    2.8 ASEAN Human Rabies Vaccine Consumption (2019-2030)
    2.9 India Human Rabies Vaccine Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Human Rabies Vaccine Production Value by Manufacturer (2019-2024)
    3.2 World Human Rabies Vaccine Production by Manufacturer (2019-2024)
    3.3 World Human Rabies Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Human Rabies Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Human Rabies Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Human Rabies Vaccine in 2023
        3.5.3 Global Concentration Ratios (CR8) for Human Rabies Vaccine in 2023
    3.6 Human Rabies Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Human Rabies Vaccine Market: Region Footprint
        3.6.2 Human Rabies Vaccine Market: Company Product Type Footprint
        3.6.3 Human Rabies Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Human Rabies Vaccine Production Value Comparison
        4.1.1 United States VS China: Human Rabies Vaccine Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Human Rabies Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Human Rabies Vaccine Production Comparison
        4.2.1 United States VS China: Human Rabies Vaccine Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Human Rabies Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Human Rabies Vaccine Consumption Comparison
        4.3.1 United States VS China: Human Rabies Vaccine Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Human Rabies Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Human Rabies Vaccine Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Human Rabies Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Human Rabies Vaccine Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Human Rabies Vaccine Production (2019-2024)
    4.5 China Based Human Rabies Vaccine Manufacturers and Market Share
        4.5.1 China Based Human Rabies Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Human Rabies Vaccine Production Value (2019-2024)
        4.5.3 China Based Manufacturers Human Rabies Vaccine Production (2019-2024)
    4.6 Rest of World Based Human Rabies Vaccine Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Human Rabies Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Human Rabies Vaccine Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Human Rabies Vaccine Production (2019-2024)

5 Market Analysis by Type
    5.1 World Human Rabies Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Vero Cell
        5.2.2 BHK
        5.2.3 Chick Embryo Cell
        5.2.4 Human Diploid Cells
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Human Rabies Vaccine Production by Type (2019-2030)
        5.3.2 World Human Rabies Vaccine Production Value by Type (2019-2030)
        5.3.3 World Human Rabies Vaccine Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Human Rabies Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Pre-Exposure Vaccine
        6.2.2 Post-Exposure Vaccine
    6.3 Market Segment by Application
        6.3.1 World Human Rabies Vaccine Production by Application (2019-2030)
        6.3.2 World Human Rabies Vaccine Production Value by Application (2019-2030)
        6.3.3 World Human Rabies Vaccine Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Bharat Biotech
        7.1.1 Bharat Biotech Details
        7.1.2 Bharat Biotech Major Business
        7.1.3 Bharat Biotech Human Rabies Vaccine Product and Services
        7.1.4 Bharat Biotech Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Bharat Biotech Recent Developments/Updates
        7.1.6 Bharat Biotech Competitive Strengths & Weaknesses
    7.2 Bavarian Nordic
        7.2.1 Bavarian Nordic Details
        7.2.2 Bavarian Nordic Major Business
        7.2.3 Bavarian Nordic Human Rabies Vaccine Product and Services
        7.2.4 Bavarian Nordic Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Bavarian Nordic Recent Developments/Updates
        7.2.6 Bavarian Nordic Competitive Strengths & Weaknesses
    7.3 Sanofi-Pasteur
        7.3.1 Sanofi-Pasteur Details
        7.3.2 Sanofi-Pasteur Major Business
        7.3.3 Sanofi-Pasteur Human Rabies Vaccine Product and Services
        7.3.4 Sanofi-Pasteur Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Sanofi-Pasteur Recent Developments/Updates
        7.3.6 Sanofi-Pasteur Competitive Strengths & Weaknesses
    7.4 Chengda Bio
        7.4.1 Chengda Bio Details
        7.4.2 Chengda Bio Major Business
        7.4.3 Chengda Bio Human Rabies Vaccine Product and Services
        7.4.4 Chengda Bio Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Chengda Bio Recent Developments/Updates
        7.4.6 Chengda Bio Competitive Strengths & Weaknesses
    7.5 KANGH
        7.5.1 KANGH Details
        7.5.2 KANGH Major Business
        7.5.3 KANGH Human Rabies Vaccine Product and Services
        7.5.4 KANGH Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 KANGH Recent Developments/Updates
        7.5.6 KANGH Competitive Strengths & Weaknesses
    7.6 Prcmise
        7.6.1 Prcmise Details
        7.6.2 Prcmise Major Business
        7.6.3 Prcmise Human Rabies Vaccine Product and Services
        7.6.4 Prcmise Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Prcmise Recent Developments/Updates
        7.6.6 Prcmise Competitive Strengths & Weaknesses
    7.7 Henan Grand Biopharma
        7.7.1 Henan Grand Biopharma Details
        7.7.2 Henan Grand Biopharma Major Business
        7.7.3 Henan Grand Biopharma Human Rabies Vaccine Product and Services
        7.7.4 Henan Grand Biopharma Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Henan Grand Biopharma Recent Developments/Updates
        7.7.6 Henan Grand Biopharma Competitive Strengths & Weaknesses
    7.8 Zhuoyi Biological
        7.8.1 Zhuoyi Biological Details
        7.8.2 Zhuoyi Biological Major Business
        7.8.3 Zhuoyi Biological Human Rabies Vaccine Product and Services
        7.8.4 Zhuoyi Biological Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Zhuoyi Biological Recent Developments/Updates
        7.8.6 Zhuoyi Biological Competitive Strengths & Weaknesses
    7.9 ZhongKe Biopharm
        7.9.1 ZhongKe Biopharm Details
        7.9.2 ZhongKe Biopharm Major Business
        7.9.3 ZhongKe Biopharm Human Rabies Vaccine Product and Services
        7.9.4 ZhongKe Biopharm Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 ZhongKe Biopharm Recent Developments/Updates
        7.9.6 ZhongKe Biopharm Competitive Strengths & Weaknesses
    7.10 Ningbo Rongan Biological
        7.10.1 Ningbo Rongan Biological Details
        7.10.2 Ningbo Rongan Biological Major Business
        7.10.3 Ningbo Rongan Biological Human Rabies Vaccine Product and Services
        7.10.4 Ningbo Rongan Biological Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Ningbo Rongan Biological Recent Developments/Updates
        7.10.6 Ningbo Rongan Biological Competitive Strengths & Weaknesses
    7.11 Indian Immunologicals
        7.11.1 Indian Immunologicals Details
        7.11.2 Indian Immunologicals Major Business
        7.11.3 Indian Immunologicals Human Rabies Vaccine Product and Services
        7.11.4 Indian Immunologicals Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Indian Immunologicals Recent Developments/Updates
        7.11.6 Indian Immunologicals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Human Rabies Vaccine Industry Chain
    8.2 Human Rabies Vaccine Upstream Analysis
        8.2.1 Human Rabies Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Human Rabies Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Human Rabies Vaccine Production Mode
    8.6 Human Rabies Vaccine Procurement Model
    8.7 Human Rabies Vaccine Industry Sales Model and Sales Channels
        8.7.1 Human Rabies Vaccine Sales Model
        8.7.2 Human Rabies Vaccine Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Human Rabies Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Human Rabies Vaccine Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Human Rabies Vaccine Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Human Rabies Vaccine Production Value Market Share by Region (2019-2024)
 Table 5. World Human Rabies Vaccine Production Value Market Share by Region (2025-2030)
 Table 6. World Human Rabies Vaccine Production by Region (2019-2024) & (K Units)
 Table 7. World Human Rabies Vaccine Production by Region (2025-2030) & (K Units)
 Table 8. World Human Rabies Vaccine Production Market Share by Region (2019-2024)
 Table 9. World Human Rabies Vaccine Production Market Share by Region (2025-2030)
 Table 10. World Human Rabies Vaccine Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Human Rabies Vaccine Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Human Rabies Vaccine Major Market Trends
 Table 13. World Human Rabies Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World Human Rabies Vaccine Consumption by Region (2019-2024) & (K Units)
 Table 15. World Human Rabies Vaccine Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World Human Rabies Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Human Rabies Vaccine Producers in 2023
 Table 18. World Human Rabies Vaccine Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key Human Rabies Vaccine Producers in 2023
 Table 20. World Human Rabies Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Human Rabies Vaccine Company Evaluation Quadrant
 Table 22. World Human Rabies Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Human Rabies Vaccine Production Site of Key Manufacturer
 Table 24. Human Rabies Vaccine Market: Company Product Type Footprint
 Table 25. Human Rabies Vaccine Market: Company Product Application Footprint
 Table 26. Human Rabies Vaccine Competitive Factors
 Table 27. Human Rabies Vaccine New Entrant and Capacity Expansion Plans
 Table 28. Human Rabies Vaccine Mergers & Acquisitions Activity
 Table 29. United States VS China Human Rabies Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Human Rabies Vaccine Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China Human Rabies Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based Human Rabies Vaccine Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Human Rabies Vaccine Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Human Rabies Vaccine Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Human Rabies Vaccine Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers Human Rabies Vaccine Production Market Share (2019-2024)
 Table 37. China Based Human Rabies Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Human Rabies Vaccine Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Human Rabies Vaccine Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Human Rabies Vaccine Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers Human Rabies Vaccine Production Market Share (2019-2024)
 Table 42. Rest of World Based Human Rabies Vaccine Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Human Rabies Vaccine Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Human Rabies Vaccine Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Human Rabies Vaccine Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers Human Rabies Vaccine Production Market Share (2019-2024)
 Table 47. World Human Rabies Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Human Rabies Vaccine Production by Type (2019-2024) & (K Units)
 Table 49. World Human Rabies Vaccine Production by Type (2025-2030) & (K Units)
 Table 50. World Human Rabies Vaccine Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Human Rabies Vaccine Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Human Rabies Vaccine Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Human Rabies Vaccine Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Human Rabies Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Human Rabies Vaccine Production by Application (2019-2024) & (K Units)
 Table 56. World Human Rabies Vaccine Production by Application (2025-2030) & (K Units)
 Table 57. World Human Rabies Vaccine Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Human Rabies Vaccine Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Human Rabies Vaccine Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Human Rabies Vaccine Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Bharat Biotech Basic Information, Manufacturing Base and Competitors
 Table 62. Bharat Biotech Major Business
 Table 63. Bharat Biotech Human Rabies Vaccine Product and Services
 Table 64. Bharat Biotech Human Rabies Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Bharat Biotech Recent Developments/Updates
 Table 66. Bharat Biotech Competitive Strengths & Weaknesses
 Table 67. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
 Table 68. Bavarian Nordic Major Business
 Table 69. Bavarian Nordic Human Rabies Vaccine Product and Services
 Table 70. Bavarian Nordic Human Rabies Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Bavarian Nordic Recent Developments/Updates
 Table 72. Bavarian Nordic Competitive Strengths & Weaknesses
 Table 73. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
 Table 74. Sanofi-Pasteur Major Business
 Table 75. Sanofi-Pasteur Human Rabies Vaccine Product and Services
 Table 76. Sanofi-Pasteur Human Rabies Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Sanofi-Pasteur Recent Developments/Updates
 Table 78. Sanofi-Pasteur Competitive Strengths & Weaknesses
 Table 79. Chengda Bio Basic Information, Manufacturing Base and Competitors
 Table 80. Chengda Bio Major Business
 Table 81. Chengda Bio Human Rabies Vaccine Product and Services
 Table 82. Chengda Bio Human Rabies Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Chengda Bio Recent Developments/Updates
 Table 84. Chengda Bio Competitive Strengths & Weaknesses
 Table 85. KANGH Basic Information, Manufacturing Base and Competitors
 Table 86. KANGH Major Business
 Table 87. KANGH Human Rabies Vaccine Product and Services
 Table 88. KANGH Human Rabies Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. KANGH Recent Developments/Updates
 Table 90. KANGH Competitive Strengths & Weaknesses
 Table 91. Prcmise Basic Information, Manufacturing Base and Competitors
 Table 92. Prcmise Major Business
 Table 93. Prcmise Human Rabies Vaccine Product and Services
 Table 94. Prcmise Human Rabies Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Prcmise Recent Developments/Updates
 Table 96. Prcmise Competitive Strengths & Weaknesses
 Table 97. Henan Grand Biopharma Basic Information, Manufacturing Base and Competitors
 Table 98. Henan Grand Biopharma Major Business
 Table 99. Henan Grand Biopharma Human Rabies Vaccine Product and Services
 Table 100. Henan Grand Biopharma Human Rabies Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Henan Grand Biopharma Recent Developments/Updates
 Table 102. Henan Grand Biopharma Competitive Strengths & Weaknesses
 Table 103. Zhuoyi Biological Basic Information, Manufacturing Base and Competitors
 Table 104. Zhuoyi Biological Major Business
 Table 105. Zhuoyi Biological Human Rabies Vaccine Product and Services
 Table 106. Zhuoyi Biological Human Rabies Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. Zhuoyi Biological Recent Developments/Updates
 Table 108. Zhuoyi Biological Competitive Strengths & Weaknesses
 Table 109. ZhongKe Biopharm Basic Information, Manufacturing Base and Competitors
 Table 110. ZhongKe Biopharm Major Business
 Table 111. ZhongKe Biopharm Human Rabies Vaccine Product and Services
 Table 112. ZhongKe Biopharm Human Rabies Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. ZhongKe Biopharm Recent Developments/Updates
 Table 114. ZhongKe Biopharm Competitive Strengths & Weaknesses
 Table 115. Ningbo Rongan Biological Basic Information, Manufacturing Base and Competitors
 Table 116. Ningbo Rongan Biological Major Business
 Table 117. Ningbo Rongan Biological Human Rabies Vaccine Product and Services
 Table 118. Ningbo Rongan Biological Human Rabies Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. Ningbo Rongan Biological Recent Developments/Updates
 Table 120. Ningbo Rongan Biological Competitive Strengths & Weaknesses
 Table 121. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
 Table 122. Indian Immunologicals Major Business
 Table 123. Indian Immunologicals Human Rabies Vaccine Product and Services
 Table 124. Indian Immunologicals Human Rabies Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 125. Indian Immunologicals Recent Developments/Updates
 Table 126. Indian Immunologicals Competitive Strengths & Weaknesses
 Table 127. Global Key Players of Human Rabies Vaccine Upstream (Raw Materials)
 Table 128. Global Human Rabies Vaccine Typical Customers
 Table 129. Human Rabies Vaccine Typical Distributors


List of Figures
 Figure 1. Human Rabies Vaccine Picture
 Figure 2. World Human Rabies Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Human Rabies Vaccine Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Human Rabies Vaccine Production (2019-2030) & (K Units)
 Figure 5. World Human Rabies Vaccine Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Human Rabies Vaccine Production Value Market Share by Region (2019-2030)
 Figure 7. World Human Rabies Vaccine Production Market Share by Region (2019-2030)
 Figure 8. North America Human Rabies Vaccine Production (2019-2030) & (K Units)
 Figure 9. Europe Human Rabies Vaccine Production (2019-2030) & (K Units)
 Figure 10. China Human Rabies Vaccine Production (2019-2030) & (K Units)
 Figure 11. India Human Rabies Vaccine Production (2019-2030) & (K Units)
 Figure 12. Human Rabies Vaccine Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Human Rabies Vaccine Consumption (2019-2030) & (K Units)
 Figure 15. World Human Rabies Vaccine Consumption Market Share by Region (2019-2030)
 Figure 16. United States Human Rabies Vaccine Consumption (2019-2030) & (K Units)
 Figure 17. China Human Rabies Vaccine Consumption (2019-2030) & (K Units)
 Figure 18. Europe Human Rabies Vaccine Consumption (2019-2030) & (K Units)
 Figure 19. Japan Human Rabies Vaccine Consumption (2019-2030) & (K Units)
 Figure 20. South Korea Human Rabies Vaccine Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN Human Rabies Vaccine Consumption (2019-2030) & (K Units)
 Figure 22. India Human Rabies Vaccine Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of Human Rabies Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Rabies Vaccine Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Rabies Vaccine Markets in 2023
 Figure 26. United States VS China: Human Rabies Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Human Rabies Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Human Rabies Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Human Rabies Vaccine Production Market Share 2023
 Figure 30. China Based Manufacturers Human Rabies Vaccine Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Human Rabies Vaccine Production Market Share 2023
 Figure 32. World Human Rabies Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Human Rabies Vaccine Production Value Market Share by Type in 2023
 Figure 34. Vero Cell
 Figure 35. BHK
 Figure 36. Chick Embryo Cell
 Figure 37. Human Diploid Cells
 Figure 38. Others
 Figure 39. World Human Rabies Vaccine Production Market Share by Type (2019-2030)
 Figure 40. World Human Rabies Vaccine Production Value Market Share by Type (2019-2030)
 Figure 41. World Human Rabies Vaccine Average Price by Type (2019-2030) & (US$/Unit)
 Figure 42. World Human Rabies Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 43. World Human Rabies Vaccine Production Value Market Share by Application in 2023
 Figure 44. Pre-Exposure Vaccine
 Figure 45. Post-Exposure Vaccine
 Figure 46. World Human Rabies Vaccine Production Market Share by Application (2019-2030)
 Figure 47. World Human Rabies Vaccine Production Value Market Share by Application (2019-2030)
 Figure 48. World Human Rabies Vaccine Average Price by Application (2019-2030) & (US$/Unit)
 Figure 49. Human Rabies Vaccine Industry Chain
 Figure 50. Human Rabies Vaccine Procurement Model
 Figure 51. Human Rabies Vaccine Sales Model
 Figure 52. Human Rabies Vaccine Sales Channels, Direct Sales, and Distribution
 Figure 53. Methodology
 Figure 54. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals

Related Reports

Global Human Rabies Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Human Rabies Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.

Global Human Rabies Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Human Rabies Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 13 Sep 2024

date Pharma & Healthcare

Global Human Rabies Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Global Human Rabies Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

date 02 Jan 2025

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Rabies Vaccine market size was valued at US$ 1137 million in 2024 and is forecast to a readjusted size of USD 1512 million by 2031 with a CAGR of 4.2% during review period.

Product Tags

Freeze-Dried Human Rabies Vaccine (Human Diploid Cells)

Human Rabies Vaccine

Freeze-dried Human Rabies Vaccine

Human Rabies Vaccine (Vero Cell)

Freeze-dried Human Rabies Vaccine (Vero Cells)

Human Rabies Vaccine Antibody Testing Service

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>